Hytham Al‐Masri

Agreement between Programmed Cell Death Ligand-1 Diagnostic Assays across Multiple Protein Expression Cutoffs in Non–Small Cell Lung Cancer

M. Ratcliffe, Alan Sharpe, Anita Midha et al. · Clinical Cancer Research · 2017 · 304 citations

Medicine, Oncology, Cancer Immunology +16

Analysis of expression of heat shock protein-90 (HSP90) and the effects of HSP90 inhibitor (17-AAG) in multiple myeloma

Jan Erik Duus, Hakki I. Bahar, Girish Venkataraman et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2006 · 62 citations

Medicine, Cell Biology, Pharmacology +13

Concordance among four commercially available, validated programmed cell death ligand-1 assays in urothelial carcinoma

M Zając, Marietta Scott, M. Ratcliffe et al. · Diagnostic Pathology · 2019 · 47 citations · Full text

Medicine, Oncology, Pathology +17

The significance of the diagnosis of atypia in breast fine‐needle aspiration

Jennifer C. Lim, Hytham Al‐Masri, Alia Salhadar et al. · Diagnostic Cytopathology · 2004 · 38 citations

Medicine, Pathology, Surgery +17

Syncope from dynamic left ventricular outflow tract obstruction simulating hypertrophic cardiomyopathy in a patient with primary AL-type amyloid heart disease.

José-Luis E Velazquez-Ceceña, David Lubell, Nagapradeep Nagajothi et al. · PubMed · 2009 · 13 citations

Medicine, Cardiology, Pathology +7